N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine Moligand™, ≥98%(HPLC)
N136726-100MG / 100MG
CAS No.:73029-73-9
N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine Moligand™, ≥98%(HPLC)
N136726-10MG / 10MG
CAS No.:73029-73-9
N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine Moligand™, ≥98%(HPLC)
N136726-1MG / 1MG
CAS No.:73029-73-9
N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine Moligand™, ≥98%(HPLC)
N136726-25MG / 25MG
CAS No.:73029-73-9
N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine Moligand™, ≥98%(HPLC)
N136726-50MG / 50MG
CAS No.:73029-73-9
N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine Moligand™, ≥98%(HPLC)
N136726-5MG / 5MG
CAS No.:73029-73-9
N-ethylacrylamide ≥98%, contains 150-400 ppm MEHQ as inhibitor
N136947-250MG / 250MG
CAS No.:5883-17-0